載入...
Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
Long-acting muscarinic antagonists (LAMAs), along with long-acting β(2)-agonists (LABAs), are the mainstay for treatment of patients with COPD. Glycopyrrolate, or glycopyrronium bromide, like other LAMAs, inhibits parasympathetic nerve impulses by selectively blocking the binding of acetylcholine to...
Na minha lista:
| 發表在: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6003532/ https://ncbi.nlm.nih.gov/pubmed/29928118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S162646 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|